New diabetes pill study aims to improve blood sugar control
NCT ID NCT05926414
First seen Sep 30, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This study looks at how well Envlo or Envlomet SR tablets control blood sugar in 15,000 adults with type 2 diabetes over 24 weeks. Participants take the medicine as part of their normal care. The goal is to see if these tablets safely lower blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NaRi Kim
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.